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Table 1. Demographic characteristics and laboratory ﬁndings of patients with
and without ED
Variables
Patients
without ED
(n¼90)
Patients
with ED
(n¼110) P
Age (years) 53.29.4 58.58.2 <0.001
Diabetes Mellitus n (%) 8(8.8) 21 (19.1) 0.05
Smoking n (%) 25(27.8) 42(38.2) 0.06
Body Mass Index 29.03.3 29.44.3 0.45
Systolic Blood Pressure (mm/Hg) 145.517.4 145.722.2 0.94
Diastolic Blood Pressure (mm/Hg) 89.812.5 87.712.4 0.46
Fasting Blood Glucose (mg/dL) 99.320.4 112.437.8 0.003
Urea (mg/dL) 28.111.7 26.712.7 0.46
Creatinine (mg/dL) 0.90.1 1.00.2 0.001
Sodium (mmol/L) 139.62.6 138.214.0 0.41
Potassium (mmol/L) 4.30.4 4.73.5 0.33
Uric acid (mg/dL) 5.441.32 6.201.6 0.01
Glomerular Filtration Rate (ml/
minutes)
117.321.3 103.125.7 <0.001
Diuretics 38 (42.2) 34 (31.0) 0.74
Beta Blockers n (%) 16 (17.8) 34 (30.9) 0.04
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Evaluation of Cardiac Biomarkers and Right Ventricular Dysfunction for Risk
Stratiﬁcation in Patients with Acute Pulmonary Embolism
Nes¸e Dursunoglu1, Dursun Dursunoglu2, Ali _Ihsan Yıldız1
1Pamukkale University Medical Faculty, Department of Chest, Pamukkale,
2Pamukkale University Medical Faculty, Department of Cardiology, Pamukkale
Objectives: Right ventricular (RV) dysfunction with myocardial damage may lead to
fatal complications in patients with acute pulmonary embolism (PE). Cytoplasmic
heart-type fatty acid binding protein (H-FABP) and N-terminal fragment of its pro-
hormone (NTproBNP) are sensitive and speciﬁc biomarkers of myocardial damage.
We evaluated RV dysfunction and cardiac biomarkers for myocardial damage and
short-term risk stratiﬁcation in patients with acute PE.Methods: We analyzed 41 patients (24 female, 17 male) with conﬁrmed acute PE.
Three groups (massive, submassive and non-massive) of patients were deﬁned, based
on systemic systolic blood pressure measured on admission and the RV dysfunction
by transthoracic echocardiography (TTE). Also, systolic (s) and mean (m) pulmonary
artery pressures (PAP) were recorded by TTE, and plasma concentrations of cardiac
troponin T (cTnT), myoglobin (Mb), NT-proBNP, and H-FABP were analyzed.
Results: Twelve (29,3%) patients died (3 PE related deaths) and 17 (41,5%) expe-
rienced complicated clinical course- in 6 month follow-up- the combined end-point
including at least one of the following: death, chronic PE, pulmonary hypertension
and recurrent PE. Hazard ratio analysis demonstrated that PAPs, PAPm, plasma H-
FABP, NT-proBNP, cTnT and Mb concentrations predicted fatal outcome. When only
PE-related deaths were considered, PAPs, plasma H-FABP and NT-proBNP
concentrations indicated fatal outcome. Multivariate hazard ratio analysis revealed H-
FABP, NT-proBNP and PAPs as the only 6-month mortality predictor. (HR 1.02 CI
95% 1.01–1.05, 1.01 CI 95% 1.01–1.04 and 1.02 CI 95% 1.02–1.05 respectively).
Conclusions: H-FABP, NT-proBNP and PAPs measured on admission are useful for
short-term risk stratiﬁcation and in the prediction of 6-month PE-related mortality in
patients with acute PE.OP-039
P-wave and QT Dispersions for Predicting Early Death in Patients with
Pulmonary Embolism
Çagdas¸ Akgüllü, Ufuk Eryılmaz, Evrin Dagtekin, Mehmet Akdeniz, Hasan Güngör,
Cemil Zencir, Tarkan Tekten, Osman Alper Onbas¸ılı, Ceyhun Ceyhan
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Background: Despite advanced therapeutic options, acute pulmonary embolism (PE)
is still related to high mortality and morbidity rates. Determination of the high risk
patients requiring more aggressive therapy and close monitoring remains an important
issue. Acute pulmonary embolism increases the pressures of the right heart chambers
and may cause various reﬂections that can be detected on surface electrocardiography
(ECG). We aimed to demonstrate relations of QT and P wave dispersions with early
death in the course of acute pulmonary embolism.
Methods: The archive data of 54 patients who had been hospitalized in our hospital with
the diagnosis of PE (whom had ﬁnal diagnosis after the exact demonstration of thrombus
in pulmonary arteries via computed tomography) between January 2012 and April 2013
was retrospectively reviewed. 33 patients whowere in sinus rhythm andwhose datawere
suitable for QT interval and P wave analyses were included to the study. ECG's obtained
within the ﬁrst 12 hours of hospital admission were included in the study. Patients with
atrial ﬁbrillation during admission or excessive noises in ECG were excluded from the
study. Retrospective analyses of corrected QT interval dispersions and P wave disper-
sions were performed for each patients. Three consecutive beats were used for the
analyses where at least 10 leads were analyzable in ECGs.
Results: Among the study population, 7 patients (%21,2) died and 26 patients
(%78,8) lived after the diagnosis of PE. P wave dispersion values of deaths were
signiﬁcantly higher than those who survived (73 (69,5-82,5) versus 51 (39,6-57,6)
respectively, p¼0,000). Moreover, QTcd values of deaths were also signiﬁcantly
higher than the survivors (119 (103-120) versus 76 (66,5-88,5) respectively,
p¼0,000). There was not any signiﬁcant difference between the survivors and deaths
by means of age, gender, smoking habit, D-dimer levels and accompanying diseases
like diabetes, hypertension, malignity, chronic obstructive pulmonary disease (COPD)
and deep venous thrombosis (p>0,05). Troponin I serum levels were signiﬁcantly
higher in deaths (15,913,8 versus 2,110,2, p¼0,01) and hemoglobin levels were
signiﬁcantly lower (10,6 (9-11,3) versus 12 (11-13,3), p¼0,034).
Conclusions: To the best of our knowledge this study, for the ﬁrst time demonstrated
close relation of Pd with early death in the course of acute PE. In order, to detect those
who were under potential high risk and who need more aggressive treatment, ECG
parameters like Pd and QTcd may be used as useful markers.
Table 1
Age 63 (51-75)
Female sex 14 (%42,4)
Male sex 19 (%57,6)
Diabetes mellitus 17 (%51,5)
Hypertension 23 (%69,7)
Chronic obstructive pulmonary disease 10 (%30,3)
Deep venous thrombosis 5 (%15,2)
History of malignancy 3 (%9,1)
Hemodynamic Instability 27 (%81,8)
Total hospitalization time 8,39 (6,5-10) days
Hospitalization to death time 6,5 (2-10) days
Death 7 (%21,2)
Survivors 26 (%78,8)
Smoking 16 (%48,5)
Thrombolytic therapy 5 (%15,2)
Minor bleeding 4 (%12,1)
Major bleeding 0 (%0)
Troponin I 5 (0 – 1,3) mg/dl
D-dimer 3800 (2054-5300)
Hemogram 11,58 (10,65-12,9)
QT dispersion 77 (68-94,3)
P wave dispersion 55,5 (41,8-63,5)
Longest P wave duration 104,5 (95,8-114,5)
Shortest P wave duration 45,5 (41,5-54,5)
Baseline characteristics of the study population.
Table 2
Deaths
(n¼7)
Survivors
(n¼26) p
Age 70(64-77) 62 (50-75) 0,330
Female Sex
Male sex
2 (%28,6)
5 (%71,4)
12 (%46,2)
14 (%53,8)
0,670
Deep venous
thrombosis
1 (%14,3) 4 (%15,4) 1,0
Diabetes mellitus 3 (%42,9) 14 (%53,8) 0,688
Hypertension 5 (%71,4) 18 (%69,2) 1,0
Chronic obstructive
pulmonary disease
1 (%14,3) 9 (%34,6) 0,397
Malignancy 2 (%28,6) 1 (%3,8) 0,106
Smoking 5 (%71,4) 11 (%42,3) 0,225
Hemodynamic
Instability
4 (%57,1) 23 (%88,5) 0,93
Corrected QT
interval dispersion
119 (103-120) 76 (66,5-88,5) 0,000
P wave dispersion 73 (69,5-82,5) 51 (39,6-57,6) 0,000
Hemoglobin 10,6 (9-11,3) 12 (11-13,3) 0,034
Troponin I 17 (1,4-27) 0 (0,0-0,0) 0,01
D-dimer 5200 (3200-5800) 3650 (1600-5150) 0,268
Thrombolytic
administered
not-administered
2 (%28,6)
5 (%71,4)
3 (%11,5)
23 (%88,5)
0,282
Minor bleeding 1 (%14,3) 3 (%11,5) 1,0
Comparison of baseline characteristics of the deaths and survivors in the course of acute
pulmonary embolism.
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Risk factors and Predictors in the Development of Pulmonary Hypertension
in Scleroderma Patients
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1Hacettepe University Faculty of Medicine Department of Cardiology, Ankara,
2Hacettepe University Faculty of Medicine Department of Rheumatology, Ankara
Introduction: Scleroderma is a chronic inﬂammatory and autoimmune disease that
leads to ﬁbrosis of the skin and visceral organs. Although interstitial pulmonary
ﬁbrosis is the most common pulmonary manifestation, pulmonary hypertension due to
pulmonary vasculopathy is also seen frequently. It is important to determine patients at
risk of developing pulmonary hypertension for prognostic reasons. In this study, risk
factors and predictors associated with the development of pulmonary hypertension in
scleroderma patients were studied.
Materials-Methods: A total of 160 patents were included in this study. A detail history
was taken, physical examination was performed, electrocardiography was obtained and
pulmonary hypertension was diagnosed ﬁrst by transthoracic echocardiography which
was then followed by right heart catheterization where the systolic, diastolic and mean
pulmonary artery pressures were obtained. High resolution computed tomography was
used to scan for interstitial pulmonary disease; besides routine biochemistry, inﬂam-
matory parameters and autoantibodies were also determined.
Results: Pulmonary hypertension was found in 15% of the patients. In univariate
analysis, the degree of tricuspid regurgitation, right ventricular diastolic diameter,
presence of pericardial effusion, pulmonary artery diameter in tomography, hemo-
globin and BNP levels were found to be associated with the development of
pulmonary hypertension. In multivariate analysis, only pulmonary artery diameter
measured in tomography and the degree of tricuspid regurgitation measured by
echocardiography were found to independent predictors of pulmonary hypertension
(p values of 0.002 and <0.001 respectively). The risk of development of pulmonary
hypertension was higher in patients with a pulmonary artery diameter >27 mm as
compared to those with a diameter 27 mm (Fig. 1 and 2). The sensitivity of
pulmonary artery diameter as a predictor was 79.1% and speciﬁcity was 92.6%,
positive predictive value was 65.5% and negative predictive value was 96.2%.
Discussion: Pulmonary hypertension accompanying scleroderma causes a signiﬁcant
decrease in survival of these patients. The determination of patients at risk of
developing pulmonary hypertension is very important for intensiﬁcation of therapy
and early intervention. In this study, pulmonary artery diameter measured in computed
tomography was found to predict scleroderma patients at risk of developing pulmo-
nary hypertension with a high accuracy and early in the course of the disease.ol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORALS
